SYNAIRGEN LIMITED
Company number 05233429 · Monitor this company
Executive summary
Synairgen Limited is in liquidation, indicating terminal financial distress and the cessation of all business operations. The recent corporate downgrade from a PLC to a Private Limited Company, combined with a minimal £11 share capital and the resignation of key directors, confirms the company is being wound down rather than rehabilitated. The prognosis is permanent closure, with current efforts solely focused on the orderly dissolution of remaining assets and the settlement of creditor obligations.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2004-09-16
- Registered office
- 4th Floor 95 Gresham Street, London, EC2V 7AB
- Postcode
- EC2V 7AB
- Capital
- 11 GBP
- Accounts category
- Group
Accounts
- Last made up to
- 2025-12-31
- Next due by
- 2027-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2025-09-16
- Next due by
- 2026-09-30
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 4 current · 17 resigned
Group structure 1 subsidiary
-
SYNAIRGEN RESEARCH LIMITED Liquidation
From persons-with-significant-control filings on the public register.
Contact details
- Website
- synairgen.com
A drug discovery company specialising in respiratory diseases with a focus on asthma and chronic obstructive pulmonary disease (COPD)
Previous company names
| Name | Date changed |
|---|---|
| SYNAIRGEN PLC | 2025-05-19 |
| SYNAIRGEN RESEARCH PLC | 2004-10-12 |
Previous registered addresses 1
| Address | Changed on |
|---|---|
| 2 VENTURE ROAD, CHILWORTH SCIENCE PARK, SOUTHAMPTON, SO16 7NP | 2007-06-17 |
The class of 2004
37%
of the 135,821 companies incorporated in 2004 are still active today; 61% have since been dissolved.
A fact about the year, not a forecast for this company.